alpha(1)-adrenoceptors mediate some of the main actions of the natural cate
cholamines, adrenaline, and noradrenaline. They participate in many essenti
al physiological processes, such as sympathetic neurotransmission, modulati
on of hepatic metabolism, control of vascular tone, cardiac contraction, an
d the regulation of smooth muscle activity in the genitourinary system. It
is now clear that alpha(1)-adrenoceptors mediate, in addition to immediate
effects, longer term actions of catecholamines such as cell growth and prol
iferation. In fact, adrenoceptor genes can be considered as protooncogenes.
Over the past years, considerable progress has been achieved in the molecul
ar characterization of different alpha(1)-adrenoceptor subtypes. Three main
subtypes have been characterized pharmacologically and in molecular terms.
Splice variants, truncated isoforms, and polymorphisms have also been dete
cted. Similarly, it is now clear that these receptors are coupled to severa
l classes of G proteins that, therefore, are capable of modulating differen
t signaling pathways.
In the present article, some of these aspects are reviewed, together with t
he distribution of the subtypes in different tissues and some of the known
roles of these receptors in health and disease. (C) 2000 IMSS. Published by
Elsevier Science Inc.